Already have a subscription?Sign In
Log in to see the full chart
Log in to see the full chart
November 25, 2020
Impact of the Adoption of Decentralized Clinical Trial Methods on the Technology Requirements* According to Clinical Trial Operators/Managers Worldwide**, Nov 2020 (% of respondents)
Description
II-BrandedMethodology
Data is from a November 2020 Oracle Health Sciences study titled "The Accelerated Evolution of Clinical Trials in a Pandemic Environment" conducted by Informa Engage. 252 respondents worldwide, who are involved in the operation and management of clinical trials, were surveyed online during September 21-November 11, 2020. Half of the respondents were in clinical operations (50%), holding director-level or higher positions (52%) in biopharmaceuticals, clinical research organizations, and medical device companies. Respondents were primarily located in North America (53%) and Europe (39%), with some representation from Asia-Pacific (5%) and the rest of the world (3%).Chart Title
Impact of the Adoption of Decentralized Clinical Trial Methods on the Technology Requirements* According to Clinical Trial Operators/Managers Worldwide**, Nov 2020 (% of respondents)Publication Date
November 25, 2020